Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans.
Pharmacogenet Genomics. 2023 Jul 1;33(5):91-100. doi: 10.1097/FPC.0000000000000491. Epub 2023 Apr 24.
Pharmacogenet Genomics. 2023.
PMID: 37099271
Free PMC article.
Clinical Trial.
Concentration-response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy.
Griesel R, Kawuma AN, Wasmann R, Sokhela S, Akpomiemie G, Venter WDF, Wiesner L, Denti P, Sinxadi P, Maartens G.
Griesel R, et al.
Br J Clin Pharmacol. 2022 Mar;88(3):883-893. doi: 10.1111/bcp.15177. Epub 2022 Jan 26.
Br J Clin Pharmacol. 2022.
PMID: 34954840
Free PMC article.
Item in Clipboard
Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population.
Griesel R, Sinxadi P, Kawuma A, Joska J, Sokhela S, Akpomiemie G, Venter F, Denti P, Haas DW, Maartens G.
Griesel R, et al.
J Antimicrob Chemother. 2022 Oct 28;77(11):3110-3117. doi: 10.1093/jac/dkac290.
J Antimicrob Chemother. 2022.
PMID: 36031789
Free PMC article.
Clinical Trial.
Item in Clipboard
Recycling Tenofovir in Second-line Antiretroviral Treatment With Dolutegravir: Outcomes and Viral Load Trajectories to 72 weeks.
Keene CM, Cassidy T, Zhao Y, Griesel R, Jackson A, Sayed K, Omar Z, Hill A, Ngwenya O, Van Zyl G, Flowers T, Goemaere E, Maartens G, Meintjes G.
Keene CM, et al.
J Acquir Immune Defic Syndr. 2023 Apr 15;92(5):422-429. doi: 10.1097/QAI.0000000000003157.
J Acquir Immune Defic Syndr. 2023.
PMID: 36706364
Free PMC article.
Item in Clipboard
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.
Cindi Z, Kawuma AN, Maartens G, Bradford Y, Venter F, Sokhela S, Chandiwana N, Wasmann RE, Denti P, Wiesner L, Ritchie MD, Haas DW, Sinxadi P.
Cindi Z, et al.
J Infect Dis. 2022 Nov 1;226(9):1616-1625. doi: 10.1093/infdis/jiac174.
J Infect Dis. 2022.
PMID: 35512135
Free PMC article.
Item in Clipboard
Relationship Between Tenofovir Diphosphate Concentrations in Dried Blood Spots and Virological Outcomes After Initiating Tenofovir-Lamivudine-Dolutegravir as First-Line or Second-Line Antiretroviral Therapy.
van Heerden JK, Meintjes G, Barr D, Zhao Y, Griesel R, Keene CM, Wiesner L, Galileya LT, Denti P, Maartens G.
van Heerden JK, et al.
J Acquir Immune Defic Syndr. 2024 Mar 1;95(3):260-267. doi: 10.1097/QAI.0000000000003341.
J Acquir Immune Defic Syndr. 2024.
PMID: 38408216
Free PMC article.
Item in Clipboard
Cite
Cite